MARX Biotech Co (ROCO:7731) Preferred Stock: NT$0.0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7731 MARX Biotech Co Ltd ROCO:7731
8 GF Score
Price NT$4.69
! 5 Warning Signs
View Full Analysis

What is MARX Biotech Co Preferred Stock?

MARX Biotech Co ROCO:7731 +0.43% 8 Preferred Stock is NT$0.0 Mil as of Dec. 2025. GuruFocus rates ROCO:7731 with a GF Score™ of 8/100. The stock has 5 warning signs investors should review.

Preferred stock is a special equity security that has properties of both equity and debt. MARX Biotech Co's preferred stock for the quarter that ended in Dec. 2025 was NT$0.0 Mil.

The market value of preferred stock needs to be added to the market value of common stocks in the calculation of Enterprise Value. MARX Biotech Co's Enterprise Value for the quarter that ended in Dec. 2025 was NT$2,762.7 Mil.

In the calculation of book value, the par value of preferred stocks needs to subtracted from total equity. MARX Biotech Co's Book Value per Share for the quarter that ended in Dec. 2025 was NT$0.69.

Dividends paid to preferred stocks need to be subtracted from net income in the calculation of Earnings per Share (Diluted). MARX Biotech Co's Earnings per Share (Diluted) for the six months ended in Dec. 2025 was NT$0.15.


MARX Biotech Co  (ROCO:7731) Preferred Stock Explanation

When a company needs capital but does not wish to issue debt, they may sell preferred stocks to investors.

For instance, during the financial crisis of 2008, Goldman Sachs (GS) issued a combination of preferred stock and common stock options for $5 billion of capital to Warren Buffett’s Berkshire Hathaway (BRK.A)(BRK.B). In this deal, Berkshire Hathaway paid $5 billion for 10% cumulative perpetual preferred stock and warrants to buy 43.5 million shares of Goldman Sachs at $115 a share. Goldman Sachs bought back the preferred in 2010. Guess how much money Warren Buffett made in this deal in two years? Read How Much Did Warren Buffett’s Berkshire Hathaway (BRK.B) Make on Its Goldman Sachs (GS) Preferred Stock?

1. The market value of Preferred Stocks needs to be added to the market value of common stocks in the calculation of enterprise value.

MARX Biotech Co's Enterprise Value for the quarter that ended in Dec. 2025 is calculated as

2. In the calculation of Book Value, the par value of Preferred Stocks needs to subtracted from total equity.

MARX Biotech Co's Book Value per Share for the quarter that ended in Dec. 2025 is calculated as

3. Dividends paid to Preferred Stocks need to be subtracted from net income in the calculation of earnings per share.

MARX Biotech Co's Earnings per Share (Diluted) (EPS) for the six months ended in Dec. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MARX Biotech Co Preferred Stock Related Terms


MARX Biotech Co Preferred Stock Historical Data

* Premium members only.

The historical data trend for MARX Biotech Co's Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MARX Biotech Co Preferred Stock Chart

MARX Biotech Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Preferred Stock
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

MARX Biotech Co Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Preferred Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ROCO:7731
8GF Score
MARX Biotech Co Ltd ROCO:7731
Preferred Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MARX Biotech Co Preferred Stock Calculation

Preferred Stock is a special equity security that has properties of both equity and debt. It is generally considered a hybrid instrument. Preferred stock is senior to common stock, but is subordinate to bonds in terms of claim or rights to their share of the assets of the company.

Preferred stock has priority over common stock in the payment of dividends and any payments received when a company liquidates.

Preferred stock comes in many forms. It can be:


Convertible or Non-Convertible
Cumulative or Non-Cumulative
Voting or Non-Voting
Callable or Non-Callable
Maturity Date or No Maturity Date

A preferred stock without a maturity date is called a perpetual preferred stock. These are relatively rare. A good example of perpetual preferred stock is the many series of Public Storage (PSA) preferred shares that trade on the New York Stock Exchange.

Before investing in preferred stock, it is important to know which of the above groups the stock belongs to. Is it convertible or non-convertible? Are dividends cumulative or non-cumulative?

It is also critical that an investor knows what bonds the company has in front of the preferred stock. Bondholders get paid first. So the decision to buy a preferred stock can be similar to the decision to buy a bond. But, remember, the preferred stock of a company with bonds is junior to those bonds.

Unless a preferred stock is convertible, the upside in a preferred stock investment is more limited than in a common stock investment. If a company doubles its earnings, it is usually under no more obligation to double the dividends paid to preferred shareholders than it is to double the interest paid to its bankers and bondholders.So preferred stock is very different from common stock.

Frequently Asked Questions Learn more about Preferred Stock →
What does a Preferred Stock of NT$0.0 Mil mean?
MARX Biotech Co (ROCO:7731) has a Preferred Stock of NT$0.0 Mil as of Dec. 2025. Preferred Stock represents the par value of a company's preferred shares. View historical data on MARX Biotech Co and its competitors.
Is MARX Biotech Co's Preferred Stock too high?
MARX Biotech Co's current Preferred Stock is NT$0.0 Mil. Overall, MARX Biotech Co has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does MARX Biotech Co's Preferred Stock compare to competitors?
MARX Biotech Co's Preferred Stock of NT$0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Preferred Stock for a Healthcare Providers & Services company?
A good Preferred Stock depends on the Healthcare Providers & Services industry context. However, Preferred Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Preferred Stock mean?
A high Preferred Stock can signal that a stock is expensive relative to its fundamentals. Preferred Stock represents the par value of a company's preferred shares. View historical data on MARX Biotech Co and its competitors. MARX Biotech Co's current Preferred Stock is NT$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MARX Biotech Co stock overvalued right now?
MARX Biotech Co (ROCO:7731) has a current Preferred Stock of NT$0.0 Mil. The current Preferred Stock is NT$0.0 Mil. MARX Biotech Co's overall GF Score™ is 8/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Preferred Stock calculated?
Preferred Stock is calculated from a company's financial statements. For MARX Biotech Co (ROCO:7731), the current Preferred Stock is NT$0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MARX Biotech Co Business Description

Address 5th Floor, No. 655, Bannan Road, Zhonghe district, New Taipei, TWN
MARX Biotech Co Ltd is a retail company which has developed an O2O and OMO full-channel layout in the online Internet platform and cosmeceutical retail market, and has successfully established itself in the market and Build trust and operational growth on the channel side. It has has established more than three thousand large and small cosmeceutical pharmacies in Taiwan, including: Dashu Pharmacy, Dingding Pharmacy, Cosmed, Watsons, Spring Pharmacy, New Gaoqiao Pharmacy, Anlier Pharmacies, etc.
8GF Score

Get the complete analysis for ROCO:7731

Preferred Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$4.69
Price